These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4321623)

  • 1. Pharmacology of a new centrally acting muscle relaxant (RJ-64).
    Leszkovszky GP; Tardos L
    Arzneimittelforschung; 1970 Nov; 20(11):1778-83. PubMed ID: 4321623
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacology of fletazepam a centrally-acting muscle relaxant.
    Barnett A; Goldstein J; Fiedler EP; Taber RI
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):164-74. PubMed ID: 4476200
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of control of skeletal-muscle contraction by dantrolene sodium.
    Ellis KO; Carpenter JF
    Arch Phys Med Rehabil; 1974 Aug; 55(8):362-9. PubMed ID: 4368898
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological studies of the new centrally acting muscle relaxant 4'-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride.
    Morikawa K; Oshita M; Yamazaki M; Ohara N; Mizutani F; Kato H; Ito Y; Kontani H; Koshiura R
    Arzneimittelforschung; 1987 Mar; 37(3):331-6. PubMed ID: 3593447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of N-(2,6-DIMETHYLPHENYL)-N-(1-methyl-2pyrrolidinylidene)urea, xilobam, a new centrally acting skeletal muscle relaxant.
    Gardocki JF; Hageman WE; Pruss TP
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):326-42. PubMed ID: 99099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central muscle relaxant activity of 4'-fluoro-3-(1-piperidyl) propiophenone (compound CN).
    Patnaik GK; Sabir M; Dhawan BN
    Indian J Exp Biol; 1979 Apr; 17(4):391-6. PubMed ID: 489069
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological properties of the new centrally acting muscle relaxant (R)-(+)-3-phenyl-5-[2-(1-pyrrolidinylmethyl)butyryl]isoxazole hydrochloride.
    Otsu T; Kawabata H; Horikomi K; Tanada H; Sakai K; Matsubara A; Mizuchi A
    Arzneimittelforschung; 1997 Jun; 47(6):706-9. PubMed ID: 9239447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of 4'fluoro-3-(1-piperidyl) propiophenone (compound CN), a new centrally acting skeletal muscle relaxant.
    Patnaik GK; Sabir M; Dhawan BN
    Indian J Exp Biol; 1979 Apr; 17(4):397-400. PubMed ID: 489070
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic agents for reduction of heightened muscle tonus and increased reflex activity (centrally acting muscle relaxants)].
    Streller I
    Arzneimittelforschung; 1981; Suppl 27():71-2. PubMed ID: 7197941
    [No Abstract]   [Full Text] [Related]  

  • 10. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. I. Effects on the central nervous system (author's transl)].
    Ochiai T; Yamamura M; Kudo Y; Ishida R
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):347-57. PubMed ID: 7327455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the new centrally acting muscle relaxant 7-chloro-N,N,3-trimethylbenzo[b]furan-2-carboxamide on motor and central nervous systems in rats.
    Ono H; Saito K; Kondo M; Morishita S; Kato K; Hasebe Y; Nakayama M; Kato F; Nakamura T; Satoh M
    Arzneimittelforschung; 1990 Jul; 40(7):730-5. PubMed ID: 2222548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of ambenoxan (2-(3',6'-dioxaheptyl)-aminomethyl-1:4-benzodioxane), a centrally acting muscle relaxant.
    Shapero M; Southgate PJ
    Br J Pharmacol; 1970 Feb; 38(2):263-70. PubMed ID: 4313800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central actions of neurotropic drugs assessed by reflex studies in man.
    Delwaide PJ; Schoenen J; Burton L
    Adv Neurol; 1983; 39():977-96. PubMed ID: 6140827
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacology of 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole (DS 103-282), a novel myotonolytic agent.
    Sayers AC; Bürki HR; Eichenberger E
    Arzneimittelforschung; 1980; 30(5):793-803. PubMed ID: 7190422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electromyographic tests for the evaluation of effects of myotonolytic drugs in muscular reflexogenic hyperreflexive states.
    Bonne A; Heymans W; Rosselle N
    Electromyography; 1970; 10(3):219-25. PubMed ID: 5509968
    [No Abstract]   [Full Text] [Related]  

  • 16. [Simple methods for the pharmacologic differentiation of central muscle relaxants].
    Hofrichter G; Roesch A; Roesch E; Schenk G
    Arzneimittelforschung; 1967 Feb; 17(2):242-5. PubMed ID: 5631491
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of diphenylalkyl derivatives. II. Pharmacology of beta,beta-bis-(4-aminophenyl)-propionitrile.
    Leszkovszky G; Tardos L; Lendvai J; Takács K
    Acta Physiol Acad Sci Hung; 1966; 30(2):193-206. PubMed ID: 5989867
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans.
    Iwase S; Mano T; Saito M; Ishida G
    Funct Neurol; 1992; 7(6):459-70. PubMed ID: 1338431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of new s-triazolobenzododiazepine (D-40TA) and other central muscle relaxants on spinal and supraspinal reflexes in cats.
    Chiba S; Nagawa Y
    Jpn J Pharmacol; 1973 Feb; 23(1):83-96. PubMed ID: 4541621
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacologic properties of 6-aminomethaqualone, a new quinazolinone compound with myotonolytic activity].
    Roesch E; Roesch A; Hofrichter G; Schenk G
    Arzneimittelforschung; 1971 Mar; 21(3):362-6. PubMed ID: 5107973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.